PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

IDX:OBAT Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	201,600	232,800	-	-	-	-
Enterprise Value	169,491	202,347	-	-	-	-
Last Close Price	336.00	388.00	-	-	-	-
PE Ratio	8.90	10.28	-	-	-	-
PS Ratio	1.26	1.45	-	-	-	-
PB Ratio	1.83	2.12	-	-	-	-
P/TBV Ratio	1.90	2.19	-	-	-	-
P/FCF Ratio	62.93	72.67	-	-	-	-
P/OCF Ratio	8.50	9.81	-	-	-	-
EV/Sales Ratio	1.06	1.26	-	-	-	-
EV/EBITDA Ratio	5.07	6.17	-	-	-	-
EV/EBIT Ratio	5.13	6.21	-	-	-	-
EV/FCF Ratio	52.90	63.16	-	-	-	-
Debt / Equity Ratio	0.07	0.07	0.22	0.09	0.03	0.01
Debt / EBITDA Ratio	0.23	0.23	0.24	0.11	0.03	0.01
Debt / FCF Ratio	2.32	2.32	1.50	0.27	0.05	0.01
Net Debt / Equity Ratio	-0.32	-0.32	0.05	-0.11	-0.04	-0.10
Net Debt / EBITDA Ratio	-1.07	-1.07	0.06	-0.13	-0.04	-0.09
Net Debt / FCF Ratio	-10.99	-10.99	0.37	-0.34	-0.08	-0.12
Asset Turnover	1.63	1.63	2.36	1.84	1.53	-
Inventory Turnover	4.61	4.61	4.57	5.29	4.53	-
Quick Ratio	4.39	4.39	0.97	0.45	0.16	0.42
Current Ratio	6.65	6.65	3.07	0.99	0.67	0.98
Return on Equity (ROE)	33.29%	33.29%	96.77%	68.60%	69.06%	-
Return on Assets (ROA)	20.67%	20.67%	46.21%	29.27%	33.73%	-
Return on Invested Capital (ROIC)	33.22%	41.97%	92.31%	71.73%	67.71%	87.05%
Return on Capital Employed (ROCE)	27.10%	27.10%	69.40%	67.60%	86.70%	97.80%
Earnings Yield	11.23%	9.73%	-	-	-	-
FCF Yield	1.59%	1.38%	-	-	-	-
Payout Ratio	59.29%	59.29%	85.13%	65.56%	121.12%	51.12%
Buyback Yield / Dilution	-	-	-39.53%	7.13%	-	-
Total Shareholder Return	6.70%	-	-39.53%	7.13%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.